
10 Ways to Lower Your Risk of and Prevent Stroke
Managing controllable risk factors such as high blood pressure, high blood sugar, and high cholesterol can significantly lower your chances of having a stroke.
Lifestyle changes like quitting smoking (if you smoke), maintaining a moderate weight, exercising regularly, and limiting alcohol consumption are crucial steps in stroke prevention.
Addressing sleep issues and getting treatment for atrial fibrillation (Afib) can further reduce stroke risk, highlighting the importance of comprehensive healthcare and proactive management.
Medical researchers have examined the main types of stroke to better understand who they impact, why, and what can be done to prevent them.
In this article, we'll examine 10 important stroke prevention steps and how each strategy may help lower your stroke risk.
Stroke is an emergency
Symptoms of a stroke typically appear suddenly and include:
speech difficulty
face drooping or numbness
weakness/paralysis on one side of the body
difficulty seeing or walking
confusion
a severe headache (hemorrhagic stroke)
If you or someone you're with experiences these symptoms call 911 immediately. Swift action during a stroke can prevent long-term disability and even death.
What steps can you take to lower your risk of stroke?
The risk factors for stroke fall into two categories: those you can manage and those you can't.
Risk factors you can't change include:
genetic factors, such as a family history of certain diseases or conditions that increase the risk of stroke
sex
older age
ethnicity
Many other risk factors for stroke can be managed or influenced to reduce your risk.
Let's look at these changes in more detail.
1. Manage blood pressure
High blood pressure, or hypertension, is a major risk factor for stroke. High blood pressure significantly contributes to 90% of all strokes. The higher your blood pressure, the greater the risk.
Normal blood pressure is defined as 120/80 millimeters of mercury (mm Hg). Blood pressure measurements even slightly above that have an increased risk of stroke.
Managing blood pressure doesn't get easier with age, and by age 65, 2/3 of people have hypertension.
You may be able to better manage your blood pressure by:
maintaining a moderate weight
getting regular exercise
following a heart-healthy eating plan, such as the Mediterranean diet or DASH (Dietary Approaches to Stop Hypertension) diet
reducing your sodium intake
medications
Some people may also need to take prescription medications to help lower their blood pressure and reduce stress on their blood vessels.
Good blood pressure management may prevent about 40% of strokes.
2. Manage blood sugar
Diabetes is a significant risk factor for stroke. Stroke accounts for approximately 20% of deaths in people with diabetes, and people with prediabetes have a higher stroke risk, too.
Diabetes is also closely linked to other conditions that increase the risk of stroke, including:
high blood pressure
obesity
high blood cholesterol
Managing diabetes with lifestyle changes, such as exercise and diet changes, can help reduce the risk of stroke. Some people may also need medications to help keep their blood sugar within a healthy range.
3. Improve blood cholesterol
Good blood cholesterol management isn't just about lowering bad cholesterol (LDL). Boosting good cholesterol (HDL) numbers is also important.
People with high LDL cholesterol levels may have a greater risk of an ischemic stroke, but people with low HDL cholesterol levels may have a higher risk of hemorrhagic stroke.
A healthy diet of good fats and proteins may help balance these numbers. This can include:
olive oil
avocados
fish
nuts
Some people may need statins or other medications to reduce cholesterol and lower the risk of plaque buildup in the arteries. Plaque can form into a full blockage or break off and become a clot.
4. Quit smoking, if you smoke
People who smoke have a 2 to 4 times greater risk of ischemic stroke than people who do not smoke. Smoking is a factor in nearly 15% of all stroke deaths in the United States each year.
The good news is that once you quit smoking, the benefits start right away and continue over time. Within 2 to 4 years of quitting, your smoke-related risk of stroke will have nearly reached zero.
5. Consider drinking habits
While people who drink light to moderate amounts of some types of alcohol may have a lower risk of heart disease than those who don't, the American Heart Association (AHA) notes that there may be other factors aside from alcohol consumption that provide the benefit. The AHA also notes that other behaviors, like exercising more and eating antioxidant-rich fruits, may lower your stroke risk better.
You may want to reevaluate your drinking habits if you engage in heavy alcohol use or misuse, which can significantly increase your risk of stroke. In part, that's because drinking a lot of alcohol can increase your blood pressure.
If you drink, it's best to stick to light to moderate alcohol consumption, which the AHA defines as up to one drink per day for women and up to two drinks per day for men. If you don't already drink, they say, don't start.
If you have difficulty limiting or stopping drinking, there are ways to get help. Behavioral therapy is a good place to start. Community support groups can help, too.
6. Aim for a healthy weight
Overweight and obesity are leading risk factors for stroke. They're also closely linked to other conditions or diseases that increase your risk for stroke, including high blood pressure and diabetes.
The risk of stroke in someone who has overweight is 22% higher than a person at a moderate weight. For people with obesity, the risk is 64% higher.
Weight management techniques can include getting regular exercise and taking in fewer calories.
But for some people, those changes may not be enough to lower the risk. A doctor may prescribe medications or procedures that can help you lose weight.
It's best to talk with your doctor about the right target weight for you.
7. Exercise regularly
Exercise can have a positive impact on some of the leading risk factors for stroke. It can help you:
lower blood pressure
lower blood sugar levels
lose weight or maintain a moderate weight
Exercise can support your heart health and reduce your risk of stroke. People who exercise regularly have a lower risk of stroke, and those who do have a stroke are less likely to die than people who aren't active.
Aim for moderate-intensity exercise most days of the week, even if you're not looking to lose weight. This exercise doesn't have to come from endless walking on a treadmill. Consider alternative ideas, like:
8. Take sleep seriously
Research increasingly makes it clear that poor sleep quality may increase your risk of stroke.
Poor sleep is known to cause issues like fatigue, poor memory, and even anxiety and depression.
Sleep issues linked to stroke include:
insomnia
excessive daytime sleepiness
sleep apnea
hypersomnia, or sleeping more than 9 hours a night
Doctors recommend finding a healthy balance of 7 to 8 hours of sleep. But if you can't do that alone, you can talk with your doctor about medications, techniques, and sleep aids that may help.
Having a stroke can also worsen existing sleep issues, which can increase your risk for a recurrent stroke.
9. Get treatment for atrial fibrillation (Afib)
Atrial fibrillation (AF or Afib) is a type of heart arrhythmia or irregular heartbeat. If you have Afib, you have a higher risk of stroke and blood clots.
Afib is linked to 1.9% of strokes per year. And while that may not seem like a lot, if Afib is coupled with other risk factors, the likelihood of a stroke increases.
Afib must be properly diagnosed and treated by a doctor. For many people, treatment will include medications that prevent blood clotting.
10. Focus on diet
Eating a nutritious and balanced diet can help you lose weight and positively impact other issues that can contribute to stroke risk. For instance:
Reducing sodium consumption may help lower your blood pressure.
Eating more healthy fats, like fish and heart-healthy oils, may improve your cholesterol levels.
Limiting added sugar and refined carbs can make managing your blood sugar levels easier.
You don't have to focus on counting calories. Instead, focus on eating more nutritious foods, like:
fresh fruits
vegetables
legumes
whole grains
fish
poultry
You can also help reduce your risk by skipping or limiting certain foods, such as:
refined sugars
red meat
ultra-processed foods
Making subtle changes to what you put on your plate can have a significant impact on your health.
Learn more about how diet can influence stroke risk.
The bottom line
If you have an increased risk of a stroke, you can work closely with your doctor to understand how to reduce your risk factors as much as you can.
Many of the strategies for stroke prevention can also support your overall health and may even reduce your risk of other health conditions.
But preventing stroke is not a one-size-fits-all plan. Combining these strategies to meet your individual risk factors can ultimately have a positive long-term impact on your health.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Washington Post
37 minutes ago
- Washington Post
Trump says Coca-Cola to switch to cane sugar in U.S. — just like Mexican Coke
Mexican Coke, which is made with real sugar, unlike the U.S. version sweetened with high-fructose corn syrup, has many fans — and American soda drinkers might soon have more options for getting their sweet cola fix. President Donald Trump on Wednesday wrote on Truth Social that he had been in touch with Coca-Cola executives, who he wrote had agreed to produce the nation's top-selling soft drink domestically using cane sugar, as it is done south of the border. 'I have been speaking to Coca-Cola about using REAL Cane Sugar in Coke in the United States, and they have agreed to do so,' Trump wrote. 'I'd like to thank all of those in authority at Coca-Cola.' He put in a personal plug for the product, even though the president famously drinks Diet Coke, which is made with the sugar substitute aspartame. 'This will be a very good move by them — You'll see,' he wrote. 'It's just better!' Coca-Cola did not confirm any details, but the company suggested in a statement Wednesday that any changes were still in the pipeline. 'We appreciate President Trump's enthusiasm for our iconic Coca-Cola brand,' the company said. 'More details on new innovative offerings within our Coca-Cola product range will be shared soon.' The move bore classic Trump earmarks: leaning on a private company to bend to his will, and announcing changes with more hype than details. It follows the tack taken by Health and Human Services Secretary Robert F. Kennedy Jr., who has championed a 'Make America Healthy Again' agenda that includes pushing food companies to remove artificial dyes and other additives from their products. A report by the 'MAHA Commission' in May pointed out high-fructose corn syrup as a factor in obesity and related diseases. Scientists have said there is minimal nutritional difference between sugar and high-fructose corn syrup. Coca-Cola introduced high-fructose corn syrup into its signature cola in the mid-1980s, spurred by low prices for U.S. corn that were bolstered by federal subsidies to corn farmers. Trump's announcement proved immediately unpopular with the makers of corn syrup, who suggested that importing cane sugar would be more expensive than utilizing a domestic product — and run counter to Trump's stated agenda of boosting American products and manufacturers. 'Replacing high fructose corn syrup with cane sugar doesn't make sense,' Corn Refiners Association President and CEO John Bode said in a statement on Wednesday night. 'President Trump stands for American manufacturing jobs, American farmers, and reducing the trade deficit. Replacing high fructose corn syrup with cane sugar would cost thousands of American food manufacturing jobs, depress farm income, and boost imports of foreign sugar, all with no nutritional benefit.' Soda aficionados have long sought out Coke made in Mexico, which its devotees say tastes crisper and less saccharine than its American counterpart.
Yahoo
40 minutes ago
- Yahoo
Johnson & Johnson (NYSE:JNJ) Reports Bullish Q2, Full-Year Sales Guidance is Optimistic
Multinational healthcare company Johnson & Johnson (NYSE:JNJ) beat Wall Street's revenue expectations in Q2 CY2025, with sales up 5.8% year on year to $23.74 billion. The company's full-year revenue guidance of $93.3 billion at the midpoint came in 2.1% above analysts' estimates. Its non-GAAP profit of $2.77 per share was 3.2% above analysts' consensus estimates. Is now the time to buy Johnson & Johnson? Find out in our full research report. Johnson & Johnson (JNJ) Q2 CY2025 Highlights: Revenue: $23.74 billion vs analyst estimates of $22.88 billion (5.8% year-on-year growth, 3.8% beat) Adjusted EPS: $2.77 vs analyst estimates of $2.68 (3.2% beat) The company lifted its revenue guidance for the full year to $93.3 billion at the midpoint from $92 billion, a 1.4% increase Management raised its full-year Adjusted EPS guidance to $10.85 at the midpoint, a 2.4% increase Operating Margin: 27.2%, in line with the same quarter last year Free Cash Flow Margin: 26.1%, up from 20.7% in the same quarter last year Organic Revenue rose 3% year on year (6.7% in the same quarter last year) Market Capitalization: $373.4 billion NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) announced today that Daniel Pinto, President, JPMorganChase, has been elected to its Board of Directors. 'We are thrilled to have Daniel join Johnson & Johnson's Board of Directors,' said Joaquin Duato, Chairman and Chief Executive Officer, Johnson & Johnson. Company Overview Founded in 1886 and known for its iconic red cross logo, Johnson & Johnson (NYSE:JNJ) is a global healthcare company that develops and sells pharmaceuticals, medical devices, and technologies focused on human health and well-being. Revenue Growth A company's long-term performance is an indicator of its overall quality. Any business can put up a good quarter or two, but many enduring ones grow for years. Regrettably, Johnson & Johnson's sales grew at a mediocre 6.4% compounded annual growth rate over the last five years. This fell short of our benchmark for the healthcare sector and is a rough starting point for our analysis. Long-term growth is the most important, but within healthcare, a half-decade historical view may miss new innovations or demand cycles. Johnson & Johnson's recent performance shows its demand has slowed as its annualized revenue growth of 4.9% over the last two years was below its five-year trend. We can dig further into the company's sales dynamics by analyzing its organic revenue, which strips out one-time events like acquisitions and currency fluctuations that don't accurately reflect its fundamentals. Over the last two years, Johnson & Johnson's organic revenue averaged 5% year-on-year growth. Because this number aligns with its normal revenue growth, we can see the company's core operations (not acquisitions and divestitures) drove most of its results. This quarter, Johnson & Johnson reported year-on-year revenue growth of 5.8%, and its $23.74 billion of revenue exceeded Wall Street's estimates by 3.8%. Looking ahead, sell-side analysts expect revenue to grow 2.9% over the next 12 months, a slight deceleration versus the last two years. This projection doesn't excite us and implies its products and services will see some demand headwinds. Software is eating the world and there is virtually no industry left that has been untouched by it. That drives increasing demand for tools helping software developers do their jobs, whether it be monitoring critical cloud infrastructure, integrating audio and video functionality, or ensuring smooth content streaming. Click here to access a free report on our 3 favorite stocks to play this generational megatrend. Operating Margin Johnson & Johnson has been an efficient company over the last five years. It was one of the more profitable businesses in the healthcare sector, boasting an average operating margin of 28.1%. Looking at the trend in its profitability, Johnson & Johnson's operating margin decreased by 14 percentage points over the last five years. The company's two-year trajectory also shows it failed to get its profitability back to the peak as its margin fell by 2.8 percentage points. This performance was poor no matter how you look at it - it shows its expenses were rising and it couldn't pass those costs onto its customers. In Q2, Johnson & Johnson generated an operating margin profit margin of 27.2%, in line with the same quarter last year. This indicates the company's overall cost structure has been relatively stable. Earnings Per Share We track the long-term change in earnings per share (EPS) for the same reason as long-term revenue growth. Compared to revenue, however, EPS highlights whether a company's growth is profitable. Johnson & Johnson's unimpressive 4.6% annual EPS growth over the last five years aligns with its revenue performance. This tells us it maintained its per-share profitability as it expanded. In Q2, Johnson & Johnson reported EPS at $2.77, down from $2.82 in the same quarter last year. Despite falling year on year, this print beat analysts' estimates by 3.2%. Over the next 12 months, Wall Street expects Johnson & Johnson's full-year EPS of $10 to grow 6.6%. Key Takeaways from Johnson & Johnson's Q2 Results We enjoyed seeing Johnson & Johnson beat analysts' revenue expectations this quarter. We were also glad its full-year revenue guidance exceeded Wall Street's estimates. Zooming out, we think this quarter featured some important positives. The stock traded up 2.2% to $158.61 immediately after reporting. Sure, Johnson & Johnson had a solid quarter, but if we look at the bigger picture, is this stock a buy? The latest quarter does matter, but not nearly as much as longer-term fundamentals and valuation, when deciding if the stock is a buy. We cover that in our actionable full research report which you can read here, it's free. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
World-first IVF trial reduces risk of babies inheriting diseases
Eight healthy babies have been born in the UK using a new IVF technique that successfully reduced their risk of inheriting genetic diseases from their mothers, the results of a world-first trial said Wednesday. The findings were hailed as a breakthrough which raises hopes that women with mutations in their mitochondrial DNA could one day have children without passing debilitating or deadly diseases on to the children. One out of every 5,000 births is affected by mitochondrial diseases, which cannot be treated, and include symptoms such as impaired vision, diabetes and muscle wasting. In 2015, Britain became the first country to approve an in-vitro fertilisation (IVF) technique that uses a small amount of healthy mitochondrial DNA from the egg of a donor -- along with the mother's egg and father's sperm. Some have called the result of this process "three-parent babies", though researchers have pushed back at this term because only roughly 0.1 percent of the newborn's DNA comes from the donor. The results of the much-awaited UK trial were published in several papers in the New England Journal of Medicine. - 'Important reproductive option' - Out of 22 women to undergo the treatment at the Newcastle Fertility Centre in northeast England, eight babies were born. The four boys and four girls now range from under six months to over two years old. The amount of mutated mitochondrial DNA -- which causes disease -- was reduced by 95-100 percent in six of the babies, according to the research. For the other two newborns, the amount fell by 77-88 percent, which is below the range that causes disease. This indicates the technique was "effective in reducing transmission" of diseases between mother and child, one of the studies said. The eight children are currently healthy, though one had a disturbance of their heart's rhythm which was successfully treated, the researchers said. Their health will be followed up over the coming years to see if problems arise. Nils-Goran Larsson, a Swedish reproductive expert not involved in the research, hailed the "breakthrough". The new technique offers a "very important reproductive option" for families affected by "devastating" mitochondrial diseases, he added. - Ethical review - Mitochondrial donation remains controversial and has not been approved in many countries, including the United States and France. Religious leaders have opposed the procedure because it involves the destruction of human embryos. Other opponents have expressed fears it could pave the way for genetically engineered "designer babies". An ethical review carried out by the UK's independent Nuffield Council on Bioethics was "instrumental" in conducting the new research, the council's director Danielle Hamm said Wednesday. Peter Thompson, head of the UK's Human Fertilisation and Embryology Authority which approved the procedure, said only people with a "very high risk" of passing on a mitochondrial disease would be eligible for the treatment. Ethical concerns have also been raised over the use of mitochondrial donation for infertility in Greece and Ukraine. French mitochondrial disease specialist Julie Stefann told AFP that "it is a question of the risk-benefit ratio: for a mitochondrial disease, the benefit is obvious". "In the context of infertility, it has not been proven," she added. Oxford University reproductive genetics expert Dagan Wells observed that "some scientists will be a little disappointed that so much time and effort has, so far, only led to the birth of eight children". Among the children being closely monitored are three that showed some signs of what is known as "reversal", which is still little understood. It is "a phenomenon where the therapy initially succeeds in producing an embryo with very few defective mitochondria, but by the time the child is born the proportion of abnormal mitochondria in its cells has significantly increased," he explained. dl/gv